Cargando…

SEROPREVALENCE OF ANTI-SARS-CoV-2 ANTIBODIES IN THE NORTHERN ITALY POPULATION BEFORE THE COVID-19 SECOND WAVE

OBJECTIVES: The COVID-19 pandemic is due to SARS-CoV-2 coronavirus infections. It swept across the world in the spring of 2020, and so far it has caused a huge number of hospitalizations and deaths. In the present study, the authors investigated serum anti-SARS-CoV-2 antibody prevalence in the perio...

Descripción completa

Detalles Bibliográficos
Autores principales: Berselli, Nausicaa, Filippini, Tommaso, Paduano, Stefania, Malavolti, Marcella, Modenese, Alberto, Gobba, Fabriziomaria, Borella, Paola, Marchesi, Isabella, Vivoli, Roberto, Perlini, Paola, Bellucci, Rossana, Bargellini, Annalisa, Vinceti, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nofer Institute of Occupational Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464740/
https://www.ncbi.nlm.nih.gov/pubmed/34524275
http://dx.doi.org/10.13075/ijomeh.1896.01826
_version_ 1785098535167852544
author Berselli, Nausicaa
Filippini, Tommaso
Paduano, Stefania
Malavolti, Marcella
Modenese, Alberto
Gobba, Fabriziomaria
Borella, Paola
Marchesi, Isabella
Vivoli, Roberto
Perlini, Paola
Bellucci, Rossana
Bargellini, Annalisa
Vinceti, Marco
author_facet Berselli, Nausicaa
Filippini, Tommaso
Paduano, Stefania
Malavolti, Marcella
Modenese, Alberto
Gobba, Fabriziomaria
Borella, Paola
Marchesi, Isabella
Vivoli, Roberto
Perlini, Paola
Bellucci, Rossana
Bargellini, Annalisa
Vinceti, Marco
author_sort Berselli, Nausicaa
collection PubMed
description OBJECTIVES: The COVID-19 pandemic is due to SARS-CoV-2 coronavirus infections. It swept across the world in the spring of 2020, and so far it has caused a huge number of hospitalizations and deaths. In the present study, the authors investigated serum anti-SARS-CoV-2 antibody prevalence in the period of June 1–September 25, 2020, in 7561 subjects in Modena, Northern Italy. MATERIAL AND METHODS: The study population included 5454 workers referred to testing by their companies, and 2107 residents in the Modena area who accessed testing through self-referral. RESULTS: The authors found the overall seroprevalence to be 4.7% (95% confidence interval [CI] 4.2–5.2%), which was higher in women (5.4%, 95% CI: 4.5–6.2%) than in men (4.3%, 95% CI: 3.7–4.9%), and in the oldest age groups (7.3%, 95% CI: 5.2–9.3% for persons aged 60–69 years, and 11.8%, 95% CI: 8.6–15.1%, for persons aged ≥70 years). Among the occupational categories, the highest seroprevalence was found in healthcare workers (8.8%, 95% CI: 7.0–10.5%), dealers and vehicle repairers (5.2%, 95% CI: 2.9–7.6%), and workers in the sports sector (4.0%, 95% CI: 1.8–6.1%), while there was little or no such evidence for those employed in sectors such as transport and storage, accommodation and restaurant services, and the school system. CONCLUSIONS: These results have allowed, for the first time, to assess population seroprevalence in this area of Italy severely hit by the epidemic, while at the same time identifying the subgroups at a higher risk of exposure to SARS-CoV-2.
format Online
Article
Text
id pubmed-10464740
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nofer Institute of Occupational Medicine
record_format MEDLINE/PubMed
spelling pubmed-104647402023-08-29 SEROPREVALENCE OF ANTI-SARS-CoV-2 ANTIBODIES IN THE NORTHERN ITALY POPULATION BEFORE THE COVID-19 SECOND WAVE Berselli, Nausicaa Filippini, Tommaso Paduano, Stefania Malavolti, Marcella Modenese, Alberto Gobba, Fabriziomaria Borella, Paola Marchesi, Isabella Vivoli, Roberto Perlini, Paola Bellucci, Rossana Bargellini, Annalisa Vinceti, Marco Int J Occup Med Environ Health Original Paper OBJECTIVES: The COVID-19 pandemic is due to SARS-CoV-2 coronavirus infections. It swept across the world in the spring of 2020, and so far it has caused a huge number of hospitalizations and deaths. In the present study, the authors investigated serum anti-SARS-CoV-2 antibody prevalence in the period of June 1–September 25, 2020, in 7561 subjects in Modena, Northern Italy. MATERIAL AND METHODS: The study population included 5454 workers referred to testing by their companies, and 2107 residents in the Modena area who accessed testing through self-referral. RESULTS: The authors found the overall seroprevalence to be 4.7% (95% confidence interval [CI] 4.2–5.2%), which was higher in women (5.4%, 95% CI: 4.5–6.2%) than in men (4.3%, 95% CI: 3.7–4.9%), and in the oldest age groups (7.3%, 95% CI: 5.2–9.3% for persons aged 60–69 years, and 11.8%, 95% CI: 8.6–15.1%, for persons aged ≥70 years). Among the occupational categories, the highest seroprevalence was found in healthcare workers (8.8%, 95% CI: 7.0–10.5%), dealers and vehicle repairers (5.2%, 95% CI: 2.9–7.6%), and workers in the sports sector (4.0%, 95% CI: 1.8–6.1%), while there was little or no such evidence for those employed in sectors such as transport and storage, accommodation and restaurant services, and the school system. CONCLUSIONS: These results have allowed, for the first time, to assess population seroprevalence in this area of Italy severely hit by the epidemic, while at the same time identifying the subgroups at a higher risk of exposure to SARS-CoV-2. Nofer Institute of Occupational Medicine 2022 2022-01-01 /pmc/articles/PMC10464740/ /pubmed/34524275 http://dx.doi.org/10.13075/ijomeh.1896.01826 Text en © 2006-2022 Journal hosting platform by Bentus https://creativecommons.org/licenses/by-nc/3.0/pl/This work is available in Open Access model and licensed under a Creative Commons Attribution-NonCommercial 3.0 Poland License – http://creativecommons.org/licenses/by-nc/3.0/pl/deed.en (https://creativecommons.org/licenses/by-nc/3.0/pl/) .
spellingShingle Original Paper
Berselli, Nausicaa
Filippini, Tommaso
Paduano, Stefania
Malavolti, Marcella
Modenese, Alberto
Gobba, Fabriziomaria
Borella, Paola
Marchesi, Isabella
Vivoli, Roberto
Perlini, Paola
Bellucci, Rossana
Bargellini, Annalisa
Vinceti, Marco
SEROPREVALENCE OF ANTI-SARS-CoV-2 ANTIBODIES IN THE NORTHERN ITALY POPULATION BEFORE THE COVID-19 SECOND WAVE
title SEROPREVALENCE OF ANTI-SARS-CoV-2 ANTIBODIES IN THE NORTHERN ITALY POPULATION BEFORE THE COVID-19 SECOND WAVE
title_full SEROPREVALENCE OF ANTI-SARS-CoV-2 ANTIBODIES IN THE NORTHERN ITALY POPULATION BEFORE THE COVID-19 SECOND WAVE
title_fullStr SEROPREVALENCE OF ANTI-SARS-CoV-2 ANTIBODIES IN THE NORTHERN ITALY POPULATION BEFORE THE COVID-19 SECOND WAVE
title_full_unstemmed SEROPREVALENCE OF ANTI-SARS-CoV-2 ANTIBODIES IN THE NORTHERN ITALY POPULATION BEFORE THE COVID-19 SECOND WAVE
title_short SEROPREVALENCE OF ANTI-SARS-CoV-2 ANTIBODIES IN THE NORTHERN ITALY POPULATION BEFORE THE COVID-19 SECOND WAVE
title_sort seroprevalence of anti-sars-cov-2 antibodies in the northern italy population before the covid-19 second wave
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464740/
https://www.ncbi.nlm.nih.gov/pubmed/34524275
http://dx.doi.org/10.13075/ijomeh.1896.01826
work_keys_str_mv AT bersellinausicaa seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT filippinitommaso seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT paduanostefania seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT malavoltimarcella seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT modenesealberto seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT gobbafabriziomaria seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT borellapaola seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT marchesiisabella seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT vivoliroberto seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT perlinipaola seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT belluccirossana seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT bargelliniannalisa seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave
AT vincetimarco seroprevalenceofantisarscov2antibodiesinthenorthernitalypopulationbeforethecovid19secondwave